查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球皮肤科准分子雷射市场 - 2023-2030
市场调查报告书
商品编码
1374851

全球皮肤科准分子雷射市场 - 2023-2030

Global Dermatology Excimer Laser Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

皮肤科准分子雷射是一种利用雷射光束和紫外线B（UVB）光来治疗皮肤受影响区域的雷射治疗设备。身体的任何部位都可以使用这种雷射疗法进行治疗，包括头皮。使用这些雷射治疗各种皮肤病被认为非常有效、安全且无痛。准分子雷射仅治疗受影响的皮肤区域，而光疗装置则治疗所有暴露的皮肤。治疗时间通常少于 10-15 分钟。

此外，在皮肤科准分子雷射中，光以波的形式传播，某些类型的光波非常长，而另一些类型的波长则相当短。不同波长的光对身体有不同的影响。这种波长的光可以消除导致湿疹症状的过度活跃的免疫细胞，并可以帮助受白斑影响的皮肤重新着色。当干癣仅限于较小的皮肤区域（例如手肘、手部、脚部或头皮）时，准分子雷射治疗也可以治疗干癣。这些雷射最常用于治疗此类皮肤状况。

市场动态：驱动因素

准分子雷射的采用率不断提高并不断进步

皮肤科准分子雷射在各种皮肤疾病中的日益采用以及准分子雷射的不断进步预计将在预测期内推动市场发展。皮肤科准分子雷射技术的不断进步带来了更精确和可客製化的治疗方案，特别是对于白斑和牛皮癣。这可以减少对健康组织的损害，并实现更快、更有效的治疗。

例如，2022 年 2 月 9 日，STRATA Skin Sciences, Inc. 在美国市场首次安装了其下一代准分子雷射系统 XTRAC Momentum 1.0。 XTRAC 准分子雷射技术可为患有牛皮癣、异位性皮肤炎和白斑等发炎性皮肤病的成人和儿童患者的特定皮肤治疗区域提供精确的靶向 UVB 光疗。

此外，STRATA 的新型 XTRAC Momentum 1.0 代表了最新的准分子雷射技术，与目前型号相比，可提供更高的功率和更快的重复率。 Momentum 还提供了新的使用者介面和纤薄的设计，两者都旨在改善治疗体验。

此外，准分子雷射对于治疗牛皮癣特别有效。它们可以精确定位受影响区域，减少健康皮肤的暴露。这导致越来越多地采用准分子雷射作为牛皮癣患者的主要治疗选择。准分子雷射治疗的针对性也对白斑症患者有益，它可以帮助受影响区域重新着色。患者越来越多地寻求非侵入性和高度针对性的治疗，这有助于皮肤科准分子雷射的采用。

例如，2020年8月12日，世界一流的美容和医学皮肤科雷射设备开发商和製造商LASEROPTEK Co., Ltd.在美国推出了PALLAS固态311nm UVB雷射。有效且安全的 PALLAS 雷射已获得 FDA 批准，可用于治疗白斑症、牛皮癣、异位性皮肤炎和白皮病。 PALLAS 对 308 奈米准分子雷射进行了独特的技术改进。

此外，牛皮癣、白斑、湿疹等慢性皮肤病的盛行率不断增加，FDA对更先进雷射的批准不断增加，意识的提高以及更精确的准分子雷射器开发的进步，预计将在预测期内推动市场发展。

限制

与皮肤科准分子雷射相关的併发症、准分子雷射治疗的高成本、与这些雷射技术相关的副作用以及对准分子雷射器缺乏认识等因素预计将阻碍市场。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 准分子雷射的采用率不断提高并取得进步
    • 限制
      • 雷射治疗的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 管道分析
  • 未满足的需求
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按产品类型

  • 桌上型准分子雷射器
  • 手持式准分子雷射器
  • 推车式准分子雷射器

第 8 章：按应用

  • 白斑
  • 牛皮癣
  • 湿疹
  • 白色疤痕
  • 其他的

第 9 章：最终用户

  • 医院
  • 皮肤科诊所
  • 专科诊所
  • 雷射中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • STRATA Skin Sciences, Inc.
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Shenzhen GSD Tech Co., Ltd.
  • Alma Lasers
  • Kernel Medical Equipment Co.,LTD.
  • Timpac Healthcare Pvt. Ltd.
  • KRUPA MEDI SCAN
  • Komachine Inc.
  • Optosystems Ltd.
  • DermSA
  • PhotoMedex, Inc.

第 13 章：附录

简介目录
Product Code: MD7384

Overview

Dermatology excimer laser is a device used for laser therapy by using the laser beam with ultraviolet B (UVB) light to treat the affected areas of skin. Any area of the body can be treated with this laser therapy, including the scalp. The treatment of various skin conditions with these lasers is considered highly effective, safe and painless. The excimer laser treats only the affected areas of skin as opposed to a phototherapy unit which treats all exposed skin. Treatment time is typically less than 10-15 minutes.

Moreover, in dermatology excimer lasers, light travels in waves, some types of light waves are very long and other wavelengths are quite short. Light of different wavelengths can have different effects on the body. This wavelength of light can eliminate the overactive immune cells that cause symptoms of eczema and can help re-pigment skin affected by vitiligo. Excimer laser treatments can also treat psoriasis when the condition is confined to smaller patches of skin, such as the elbows, hands, feet, or scalp. These lasers are most commonly used for such skin conditions.

Market Dynamics: Drivers

Increasing adoption and increasing advancements in excimer lasers

The increasing adoption of dermatology excimer lasers in various skin disorders and increasing advancements in excimer lasers are expected to drive the market over the forecast period. Ongoing advancements in dermatology excimer laser technology led to even more precise and customizable treatment options, especially for vitiligo and psoriasis. This results in reduced damage to healthy tissue and quicker, more effective treatments.

For instance, on February 09, 2022, STRATA Skin Sciences, Inc. launched the first installation in the U.S. market, of its next-generation excimer laser system, XTRAC Momentum 1.0. The XTRAC excimer laser technology allows for the precise delivery of targeted UVB light therapy to specific skin treatment areas, for both adult and pediatric patients suffering from inflammatory skin conditions such as psoriasis, atopic dermatitis and vitiligo.

Moreover, STRATA's new XTRAC Momentum 1.0 represents the latest in excimer laser technology, delivering higher power and a faster repetition rate than the current models. The Momentum also offers a new user interface and slim design, both intended to improve the treatment experience.

In addition, excimer lasers are particularly effective in treating psoriasis. They offer precise targeting of affected areas, reducing exposure to healthy skin. This has led to increased adoption of excimer lasers as a primary treatment option for psoriasis patients. The targeted nature of excimer laser therapy is also beneficial for vitiligo patients, where it can help repigment the affected areas. Patients are increasingly seeking non-invasive and highly targeted treatments, contributing to the adoption of the dermatology excimer lasers.

For instance, on August 12, 2020, LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology, launched its PALLAS Solid-State 311nm UVB laser in the United States. The efficacious and safe PALLAS laser is FDA-cleared for the treatment of vitiligo, psoriasis, atopic dermatitis and leukoderma. PALLAS features unique technology improvements over 308-nanometer excimer lasers.

Further, the increasing prevalence of chronic skin conditions like psoriasis, vitiligo, eczema and others, rising FDA approvals for more advanced lasers, increasing awareness and advancements in the development of more precise excimer lasers are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications associated with dermatology excimer lasers, high cost of the excimer laser therapy, side effects associated with these laser techniques and lack of awareness about the excimer lasers are expected to hamper the market.

Segment Analysis

The global dermatology excimer laser market is segmented based on product type, application, end-user and region.

The psoriasis segment accounted for approximately 49.8% of the dermatology excimer laser market share

The psoriasis segment is expected to hold the largest market share over the forecast period. The dermatology excimer lasers emit a specific wavelength of ultraviolet B light, which can be precisely targeted to affected areas of the skin. This focused treatment minimizes exposure to healthy skin, reducing the risk of side effects commonly associated with broader UVB exposure. In case of psoriasis, excimer lasers are used to slow down the growth of skin cells in affected areas and reduce inflammation, helping to manage and alleviate the symptoms of psoriasis.

Additionally, using excimer lasers for psoriasis patients results in faster clearing of psoriatic lesions compared to other treatment methods and the therapy is generally well-tolerated so this therapy is most commonly used. Patients are mostly preferring this therapy due to its non-invasive nature.

Moreover, the increasing prevalence of psoriasis is expected to the increasing adoption of dermatology excimer lasers. For psoriasis patients, excimer laser therapy provides relief that lasts several months, improves symptoms in just 6-12 sessions, is known for a quick, easy treatment that doesn't require to application of creams or products every day, provides long-term symptom remission and it also provides pain-free and non-invasive treatment.

For instance, according to the National Psoriasis Foundation, 2022, more than 8 million Americans have psoriasis. 125 million people worldwide, 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium. Psoriasis prevalence in African Americans is 1.5 percent compared to 3.6 percent of Caucasians.

Geographical Analysis

North America accounted for approximately 40.4% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of dermatology excimer lasers to treat various types of skin conditions. North America especially the United States is known for its strong presence of major players such as medical device companies and biotechnology companies which are actively focussing on the development of more advanced and precise dermatology excimer lasers for better patient outcomes. This presence of major players performs research activities for the advancements in the excimer lasers.

Furthermore, increasing adoption of dermatology excimer lasers is also expected to drive the market in the region. The region is also known for the increasing prevalence of various skin conditions, this increasing prevalence is expected to increase the demand and adoption of dermatology excimer lasers.

For instance, according to the National Eczema Association, 31.6 million people in the U.S. have some form of eczema, and prevalence peaks during early childhood and according to the National Psoriasis Foundation, more than 8 million Americans have psoriasis. This increasing prevalence of skin conditions in the region is expected to increase the adoption of dermatology excimer lasers for better treatment of skin disorders.

Competitive Landscape

The major global players in the dermatology excimer laser market include: STRATA Skin Sciences, Inc., Shenzhen GSD Tech Co., Ltd., Alma Lasers, Kernel Medical Equipment Co., LTD., Timpac Healthcare Pvt. Ltd., KRUPA MEDI SCAN, Komachine Inc., Optosystems Ltd., DermSA and PhotoMedex, Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global dermatology excimer laser market. During the pandemic, patients with dermatological conditions like psoriasis, who would have otherwise sought treatment with excimer lasers are delayed or avoided in-person visits to healthcare facilities. This was due to concerns and redirected focus towards virus exposure, restrictions on non-essential healthcare services and the reprioritization of healthcare resources. The pandemic also disrupted the supply chain of these medical devices globally due to border closures.

Market Segmentation

By Product Type

  • Table Top Excimer Lasers
  • Hand-Held Excimer Lasers
  • Trolley Mounted Excimer Lasers

By Application

  • Vitiligo
  • Psoriasis
  • Eczema
  • White Scars
  • Others

By End-User

  • Hospitals
  • Dermatology Clinics
  • Specialty Clinics
  • Laser Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Why Purchase the Report?

  • To visualize the global dermatology excimer laser market segmentation based on product type, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of dermatology excimer laser market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global dermatology excimer laser market report would provide approximately 61 tables, 61 figures, and 187 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption and Advancements in Excimer Lasers
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of the Laser Therapy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Unmet Needs
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Table Top Excimer Lasers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hand-Held Excimer Lasers
  • 7.4. Trolley Mounted Excimer Lasers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Vitiligo*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Psoriasis
  • 8.4. Eczema
  • 8.5. White Scars
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Clinics
  • 9.4. Specialty Clinics
  • 9.5. Laser Centers
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. STRATA Skin Sciences, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Shenzhen GSD Tech Co., Ltd.
  • 12.3. Alma Lasers
  • 12.4. Kernel Medical Equipment Co.,LTD.
  • 12.5. Timpac Healthcare Pvt. Ltd.
  • 12.6. KRUPA MEDI SCAN
  • 12.7. Komachine Inc.
  • 12.8. Optosystems Ltd.
  • 12.9. DermSA
  • 12.10. PhotoMedex, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us